Tagged: Health and Education
The International AIDS Conference concluded today without a clear plan or any new impetus to reach the 2010 target of universal access to HIV/AIDS prevention, treatment and care, said international agency Oxfam.
Aggressive patenting costs lives, says Oxfam. Legal maneuvering by multinational companies restricting access to essential medicines contradicts their encouraging words at the International AIDS Conference.
Inadequate donor financing and aggressive tactics by multinational pharmaceutical companies threaten to derail efforts to achieve universal access to HIV/AIDS prevention, care, treatment and support by 2010.